Serum albumin and white matter hyperintensities

• Published in: Translational psychiatry 2024-06, Vol.14 (1), p.233-11, Article 233
• Main Authors: Zahr, Natalie M., Pfefferbaum, Adolf
• Format: Article
• Language: English
• Subjects: 59/57; 631/378/1595; 692/53/2423; Adult; Alcoholism - diagnostic imaging; Alcoholism - pathology; Behavioral Sciences; Biological Psychology; Cognitive Dysfunction - blood; Cognitive Dysfunction - diagnostic imaging; Cognitive Dysfunction - pathology; Female; Hematology; HIV; HIV Infections - complications; HIV Infections - diagnostic imaging; HIV Infections - pathology; Human immunodeficiency virus; Humans; Magnetic Resonance Imaging; Male; Medicine; Medicine & Public Health; Middle Aged; Neurosciences; Pharmacotherapy; Proteins; Psychiatry; Serum Albumin - metabolism; White Matter - diagnostic imaging; White Matter - pathology
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-024-02953-5

People living with HIV and those diagnosed with alcohol use disorders (AUD) relative to healthy individuals commonly have low levels of serum albumin, substantiated as an independent predictor of cardiovascular events. White matter hyperintensities (WMH)—a neuroimaging feature of cerebral small vessel disease—are also related to cardiovascular disease. Despite consensus regarding associations between high levels of urine albumin and WMH prevalence, and low serum albumin levels and impaired cognitive functioning, relations between serum albumin and WMH burdens have rarely been evaluated. Here, a sample including 160 individuals with AUD, 142 living with HIV, and 102 healthy controls was used to test the hypothesis that serum albumin would be inversely related to WMH volumes and directly related to cognitive performance in the two diagnostic groups. Although serum albumin and periventricular WMH volumes showed an inverse relationship in both AUD and HIV groups, this relationship persisted only in the HIV group after consideration of traditional cardiovascular (i.e., age, sex, body mass index (BMI), nicotine use, hypertension, diabetes), study-relevant (i.e., race, socioeconomic status, hepatitis C virus status), and disease-specific (i.e., CD4 nadir, HIV viral load, HIV duration) factors. Further, serum albumin contributed more significantly than periventricular WMH volume to variance in performance on a verbal learning and memory composite score in the HIV group only. Relations in both HIV and AUD groups between albumin and hematological red blood cell markers (e.g., hemoglobin, hematocrit) suggest that in this sample, serum albumin reflects hematological abnormalities. Albumin, a simple serum biomarker available in most clinical settings, may therefore help identify periventricular WMH burden and performance levels in specific cognitive domains in people living with HIV. Whether serum albumin contributes mechanistically to periventricular WMH in HIV will require additional investigation.